Regeneron Pharmaceuticals, Inc.
BIS-OCTAHYDROPHENANTHRENE CARBOXAMIDES AND PROTEIN CONJUGATES THEREOF

Last updated:

Abstract:

Provided herein are compounds, compositions and methods for the treatment of diseases and disorders associated with the liver X receptor, including bis-octahydrophenanthrene carboxamides and protein (e.g., antibody) drug conjugates thereof.

Status:
Application
Type:

Utility

Filling date:

5 Oct 2021

Issue date:

14 Apr 2022